Cirdan completed the acquisition of PathXL from Philips.

Cirdan, a medical informatics and imaging technology company completed the acquisition of PathXL, digital and computational pathology business of Philips, a Dutch multinational conglomerate. Financial terms were not disclosed. "We are excited by the prospect of being able to further invest in our laboratory informatics business with this acquisition. We have shared a close relationship with key members of the PathXL team over many years and are looking forward to combining our products and resources to bring the best of each to the industry. It has been our long-term vision for our products to be global technological leaders, and with the addition of PathXL we will be able to accelerate the inclusion of deep learning and digital pathology technology," Dr. Hugh Cormican, Cirdan CEO.